Business Description
Dabomb Protein Biotech Corp
ISIN : TW0006578008
Total Employee Number:
51Compare
Compare
Traded in other countries / regions
6578.Taiwan IPO Date
2016-07-20Description
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.17 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -3.34 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 6.81 | |||||
Beneish M-Score | -2.64 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -27.3 | |||||
3-Year EBITDA Growth Rate | 8.2 | |||||
3-Year EPS without NRI Growth Rate | 6 | |||||
3-Year FCF Growth Rate | -190.1 | |||||
3-Year Book Growth Rate | -9.3 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 77.26 | |||||
9-Day RSI | 69.54 | |||||
14-Day RSI | 63.41 | |||||
3-1 Month Momentum % | -5.06 | |||||
6-1 Month Momentum % | -15.71 | |||||
12-1 Month Momentum % | -13.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.67 | |||||
Quick Ratio | 2.45 | |||||
Cash Ratio | 1.9 | |||||
Days Inventory | 37.96 | |||||
Days Sales Outstanding | 41.53 | |||||
Days Payable | 19.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.49 | |||||
5-Year Yield-on-Cost % | 2.49 | |||||
3-Year Average Share Buyback Ratio | -22.1 | |||||
Shareholder Yield % | 14.72 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 22.32 | |||||
Operating Margin % | -9.11 | |||||
Net Margin % | -22.42 | |||||
EBITDA Margin % | -7.19 | |||||
FCF Margin % | -6.8 | |||||
OCF Margin % | 5.38 | |||||
ROE % | -6.63 | |||||
ROA % | -5.67 | |||||
ROIC % | -2.95 | |||||
3-Year ROIIC % | -16.09 | |||||
ROC (Joel Greenblatt) % | -7.06 | |||||
ROCE % | -5.86 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4.01 | |||||
PB Ratio | 1.25 | |||||
Price-to-Tangible-Book | 1.26 | |||||
Price-to-Operating-Cash-Flow | 77.22 | |||||
EV-to-EBIT | -18.31 | |||||
EV-to-EBITDA | -52.06 | |||||
EV-to-Revenue | 3.74 | |||||
EV-to-FCF | -51.96 | |||||
Price-to-GF-Value | 1.19 | |||||
Price-to-Projected-FCF | 6.98 | |||||
| Price-to-Net-Current-Asset-Value | 10.42 | |||||
| Price-to-Net-Cash | 23.07 | |||||
Earnings Yield (Greenblatt) % | -5.47 | |||||
FCF Yield % | -1.69 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dabomb Protein Biotech Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 309.335 | ||
| EPS (TTM) (NT$) | -0.96 | ||
| Beta | 0.2361 | ||
| 3-Year Sharpe Ratio | -0.11 | ||
| 3-Year Sortino Ratio | -0.18 | ||
| Volatility % | 36.54 | ||
| 14-Day RSI | 63.41 | ||
| 14-Day ATR (NT$) | 0.536063 | ||
| 20-Day SMA (NT$) | 16.415 | ||
| 12-1 Month Momentum % | -13.99 | ||
| 52-Week Range (NT$) | 14.35 - 25.95 | ||
| Shares Outstanding (Mil) | 71.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dabomb Protein Biotech Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dabomb Protein Biotech Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.400000 Cash Dividend | 2025-07-08 | 19.70 (+2.07%) | ||
| TWD 0.509263 Cash Dividend | 2024-07-30 | 24.35 (-1.42%) | ||
| 1.1:1 Stock Split | 2021-08-23 | 16.67 (-0.27%) | ||
| 1.05:1 Stock Split | 2017-08-21 | 21.97 (+0.00%) | ||
| 1.05:1 Stock Split | 2016-08-25 | 26.77 (+0.00%) |
Show
Entries
Dabomb Protein Biotech Corp Frequently Asked Questions
What is Dabomb Protein Biotech Corp(ROCO:6578)'s stock price today?
The current price of ROCO:6578 is NT$17.30. The 52 week high of ROCO:6578 is NT$25.95 and 52 week low is NT$14.35.
When is next earnings date of Dabomb Protein Biotech Corp(ROCO:6578)?
The next earnings date of Dabomb Protein Biotech Corp(ROCO:6578) is .
Does Dabomb Protein Biotech Corp(ROCO:6578) pay dividends? If so, how much?
The Dividend Yield %  of Dabomb Protein Biotech Corp(ROCO:6578) is 2.49% (As of Today), Highest Dividend Payout Ratio of Dabomb Protein Biotech Corp(ROCO:6578) was 2.99. The lowest was 0.41. And the median was 0.95. The  Forward Dividend Yield % of Dabomb Protein Biotech Corp(ROCO:6578) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Dabomb Protein Biotech Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers